Not applicableStudy completedNCT00088803What this trial is testingDNA Variations in the Gene in Young Patients With Wilms' TumorWho this might be right forKidney Cancer Children's Oncology Group 471
Testing effectiveness (Phase 2)Study completedNCT00006486What this trial is testingCarboxyamidotriazole in Treating Patients With Metastatic Kidney CancerWho this might be right forRecurrent Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 335
Testing effectiveness (Phase 2)Study completedNCT00005831What this trial is testingTrastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract CancerWho this might be right forMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Bladder CancerRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+3 more National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00016237What this trial is testingInterleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous TreatmentWho this might be right forBladder CancerKidney CancerLung Cancer EMD Serono
Testing effectiveness (Phase 2)Study completedNCT03513952What this trial is testingAtezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial CarcinomaWho this might be right forAdvanced Bladder Urothelial CarcinomaAdvanced Ureter Urothelial CarcinomaMetastatic Bladder Urothelial Carcinoma+21 more National Cancer Institute (NCI) 47
Not applicableStudy completedNCT00003538What this trial is testingPrevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT01548482What this trial is testingTrebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryWho this might be right forAdult Solid NeoplasmLung Carcinoid TumorRecurrent Digestive System Neuroendocrine Tumor G1+8 more National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT00462982What this trial is testingSunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or MelanomaWho this might be right forKidney CancerMelanoma (Skin)Metastatic Cancer Memorial Sloan Kettering Cancer Center 8
Testing effectiveness (Phase 2)Ended earlyNCT00098618What this trial is testingSorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaPapillary Renal Cell CarcinomaRecurrent Renal Cell Cancer+2 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00003390What this trial is testing6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00002847What this trial is testingInterferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Blumenthal Cancer Center at Carolinas Medical Center 14
Testing effectiveness (Phase 2)Ended earlyNCT04902040What this trial is testingPlinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted AntibodiesWho this might be right forAdvanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more M.D. Anderson Cancer Center 19
Early research (Phase 1)Active Not RecruitingNCT04388852What this trial is testingDS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell CancersWho this might be right forAggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+7 more M.D. Anderson Cancer Center 65
Testing effectiveness (Phase 2)Ended earlyNCT01239342What this trial is testingAkt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney CancerWho this might be right forMetastatic Kidney CarcinomaRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+1 more National Cancer Institute (NCI) 43
Early research (Phase 1)Ended earlyNCT04060342What this trial is testingGB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaWho this might be right forPancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Not applicableWithdrawnNCT04961320What this trial is testingOccupational Therapy Fatigue Management-Based Intervention for Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8 City of Hope Medical Center
Not applicableStudy completedNCT05579847What this trial is testingFeasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination ImmunotherapyWho this might be right forRenal Cell Carcinoma Stage IV H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT02964078What this trial is testingInterleukin-2 and Pembrolizumab for Metastatic Kidney CancerWho this might be right forKidney Cancer H. Lee Moffitt Cancer Center and Research Institute 27
Testing effectiveness (Phase 2)Study completedNCT00003585What this trial is testingBiological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney CancerWho this might be right forKidney Cancer University of New Mexico 35
Testing effectiveness (Phase 2)Study completedNCT00072150What this trial is testingPhase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell CarcinomaWho this might be right forMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Bladder CancerRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+7 more National Cancer Institute (NCI) 40